Lower risk of the disease progression and chemoresistance was found in GSTP1 105Val allele carriers (Romero et al. 2012) and also in cancer patients with at least one GSTP1 105Ile allele (Zhang et al. 2011a). This evidence concerns the gene GSTP1 and cancer.